Article

Chemo-Immunotherapy, a Combination Approach for the Treatment of HER2-Positive Breast Cancer in a Mouse Model

2024-02-14

Abstract excerpt

The discovery of tumor-associated antigens has been a major milestone for cancer therapy as the current conventional therapies (radiotherapy, chemotherapy) were found to be insufficient in terms of cancer treatment. Human epidermal growth factor receptor (HER2) is a tumor-associated antigen, aberrantly found in various cancers, including breast cancer. Today, most of the treatment strategies are skewed towards com...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9be955b8-bc04-5fb2-932d-cc453f92ad65
DOI: 10.21203/rs.3.rs-3943744/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Chemo-Immunotherapy, a Combination Approach for the Treatment of HER2-Positive Breast Cancer in a Mouse ModelDOI 10.21203/rs.3.rs-3943744/v1Read

Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives.Semantic proximity Read

Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model.Semantic proximity Read

Designing and Development of a DNA Vaccine Expressing HER2/ HER3 and CCL20 as a Novel Candidate for Breast Cancer VaccineSemantic proximity Read

Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistanceSemantic proximity Read

Evaluating Immunoreactivity of Polyclonal Antibodies Developed against AU-565 Cell Line for Diagnosis and Immunotherapy of Breast CancerSemantic proximity Read

<i>In situ</i> administration of cytokine combinations induces tumor regressionSemantic proximity Read

Pilot study of p62 DNA vaccine in dogs with mammary tumorsSemantic proximity Read

PD-L1 blockade TAM-dependently potentiates mild photothermal therapy against triple-negative breast cancer.Semantic proximity Read

A new scfv-based recombinant immunotoxin against EPHA2-overexpressing breast cancer cells; High in vitro anti-cancer potency.Semantic proximity Read

Preparation of triple-negative breast cancer vaccine through electrofusion with day-3 dendritic cells.Semantic proximity Read

Accumulation of Memory Precursor CD8 T Cells in Regressing Tumors following Combination Therapy with Vaccine and Anti-PD-1 AntibodySemantic proximity Read

Enhanced immune response induced by P5 HER2/neu-derived peptide-pulsed dendritic cells as a preventive cancer vaccine.Semantic proximity Read